Ayvakit (avapritinib) is a medication that’s FDA approved in adults to treat a certain type of cancer of the digestive system called gastrointestinal stromal tumor (GIST). It also treats adults with systemic mastocytosis, a blood cancer related to immune cells called mast cells. Ayvakit (avapritinib) is a type of targeted therapy called a tyrosine kinase inhibitor. It’s a tablet that’s taken by mouth once a day on an empty stomach. Common side effects include swelling, tiredness, and nausea. It can also cause changes in memory and attention.
Ayvakit (avapritinib) is a tyrosine kinase inhibitor.
In the body, tyrosine kinases are proteins that help make sure cells grow and work normally. But in people with GIST or systemic mastocytosis, certain tyrosine kinases like PDGFRA and KIT can become overly active and cause cells to grow out of control.
Ayvakit (avapritinib) blocks the PDGFRA and KIT proteins. This helps slow down the condition’s growth.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effect percentages are from studies of people taking Ayvakit (avapritinib) for GIST. Side effects might differ for people with other types of cancer who take this medication.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No, Ayvakit (avapritinib) isn’t considered a traditional chemotherapy. Traditional chemotherapy are medications that damage and kill fast-growing cells. But Ayvakit (avapritinib) is a type of targeted therapy that works to prevent cell growth. It blocks certain proteins in the body that cause cells to divide uncontrollably.
Talk with your oncologist if Ayvakit (avapritinib) would be a treatment option for you. Currently, this medication is FDA approved to treat certain people who have GIST that’s caused by specific gene changes (mutations). Your oncologist will collect a sample of your tumor (biopsy) and test it for a specific gene change in PDGFRA exon 18. If your GIST has this mutation, Ayvakit (avapritinib) might be a treatment option for you. It's also approved for treating indolent and advanced systemic mastocytosis. Discuss with your oncologist or specialist about available treatment options for your specific condition.
How long you take Ayvakit (avapritinib) will depend on why you’re taking the medication and how well it’s working for you. It also depends on how well you can tolerate the medication’s side effects or whether you have serious side effects from it. In clinical studies, the majority of people took Ayvakit (avapritinib) for at least 6 months. Talk with your oncologist about your specific treatment plan.
In clinical studies, some people reported hair loss while they were taking Ayvakit (avapritinib). Usually, hair starts to grow back over several months after you stop treatment. Other people also noticed that their hair color changed. Speak with your oncology care team if you notice hair loss, hair thinning, or unusual hair changes while you’re taking Ayvakit (avapritinib). Your care team can recommend ways to help you manage this side effect.
Based on how Ayvakit (avapritinib) works and on animal data, it’s possible that the medication can harm an unborn baby if it’s taken during pregnancy. For this reason, it’s important to prevent pregnancy during treatment if you’re sexually active. If you or your partner can become pregnant, use effective birth control while you’re taking Ayvakit (avapritinib) and for 6 weeks after your last dose.
Avoid breastfeeding while you’re taking Ayvakit (avapritinib) and for 2 weeks after stopping the medication. Although we don’t know whether Ayvakit (avapritinib) can get into breast milk, there’s a risk that it does and that it can harm breastfeeding infants. Speak with your oncology care team or obstetrician-gynecologist (OB-GYN) about safer alternatives to breastfeeding, like using baby formula.
Based on studies done in animals, Ayvakit (avapritinib) might affect fertility, or the ability to have children at doses of 200 mg or higher. Before you start taking Ayvakit (avapritinib), talk with your oncologist or care team about resources for family planning if you’re considering becoming pregnant or fathering a child.
Ayvakit (avapritinib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Bleeding in the brain is a rare but serious side effect of Ayvakit (avapritinib). Make sure to share your complete medical history and medication list with your oncology care team. Previous strokes, brain bleeds, or swollen or ruptured blood vessels (aneurysms) and treatment with blood thinners can raise your risk of having bleeding in the brain while you’re taking Ayvakit (avapritinib).
If you’re taking Ayvakit (avapritinib) for advanced systemic mastocytosis, you’ll need to have your blood drawn to check your platelet levels before you start treatment. You’ll also get them checked every 2 to 4 weeks while you’re taking the medication. Having low platelet levels can put you at risk for bleeding in the brain. If your platelet levels get too low, your oncologist will stop your Ayvakit (avapritinib) treatment for a while and restart it at a lower dose once your platelet levels normalize.
Get medical help right away if you develop any symptoms of a brain bleed, such as a severe headache, confusion, nausea, repeated vomiting, or changes in vision, while you’re taking Ayvakit (avapritinib). You’ll have to stop taking the medication if you have a brain bleed during treatment.
People who take Ayvakit (avapritinib) can have a variety of side effects affecting the nervous system. These side effects can include confusion, forgetfulness, and speaking problems.
During clinical studies, these side effects were more common in people who took high doses of Ayvakit (avapritinib). Some people noticed these side effects within 2 to 4 months (and sometimes as early as a day) of starting the medication. Usually, the symptoms went away about 2 months after lowering the dose, pausing, or stopping treatment.
Let your healthcare team know if you have any new or worsening drowsiness, forgetfulness, problems concentrating, or problems with speaking while you’re taking Ayvakit (avapritinib). Avoid driving or doing anything that you need to concentrate on until a healthcare professional examines you. You might need to take a break from Ayvakit (avapritinib) so that you can recover from these side effects. Once your symptoms improve, you might be able to restart Ayvakit (avapritinib) at a lower dose.
Based on findings from animal studies, it’s possible for Ayvakit (avapritinib) to harm to an unborn baby if it’s taken during pregnancy. You might need to take a pregnancy test before starting treatment to make sure you’re not pregnant. Use effective birth control, such as birth control pills or condoms, while you’re taking Ayvakit (avapritinib) and for at least 6 weeks after your last dose if you’re sexually active. Let your oncologist know if you or your partner gets pregnant or plans to become pregnant while you’re taking Ayvakit (avapritinib).
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 100mg | 30 tablets | $0.00 | $0.00 |
| 200mg | 30 tablets | $0.00 | $0.00 |
| 300mg | 30 tablets | $0.00 | $0.00 |
| 25mg | 30 tablets | $0.00 | $0.00 |
| 50mg | 30 tablets | $0.00 | $0.00 |
Your oncologist might lower your dose if you have side effects from the medication (e.g., nausea, abnormal blood test results). They might also lower your dose if you have severe liver problems.
Certain blood cell cancers and conditions
Certain skin cancer
Certain tumors in the digestive tract - Gleevec brand only